DealMakers: Entrepreneur | Startups | Venture Capital
Trevor Martin On Raising $75 Million To Become A Top Contender In Combating COVID
Trevor Martin is the cofounder and CEO of Mammoth Biosciences which develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more. The company has raised over $75 million investors from top tier investors such as Mayfield Fund, 8VC, or NFX to name a few.